Free Trial

Aspira Women's Health Q1 2023 Earnings Report

Aspira Women's Health logo
$0.22 -0.01 (-4.41%)
As of 02/21/2025 03:58 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Aspira Women's Health EPS Results

Actual EPS
-$10.94
Consensus EPS
-$0.75
Beat/Miss
Missed by -$10.19
One Year Ago EPS
N/A

Aspira Women's Health Revenue Results

Actual Revenue
$2.32 million
Expected Revenue
$2.30 million
Beat/Miss
Beat by +$20.00 thousand
YoY Revenue Growth
N/A

Aspira Women's Health Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Aspira Women's Health Earnings Headlines

Elon Takes Aim at Social Security
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social Security, finding what he says is widespread fraud across the agency.
Aspira Women’s Health appoints Ellen Beausang to board of directors
See More Aspira Women's Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aspira Women's Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aspira Women's Health and other key companies, straight to your email.

About Aspira Women's Health

Aspira Women's Health (NASDAQ:AWH), Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

View Aspira Women's Health Profile

More Earnings Resources from MarketBeat